Drug intelligence / Profile preview

HypoCat

Development stage
Unknown
Lead developer
Saiba Animal Health
Modality
Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

HypoCat is a veterinary vaccine designed to neutralize the major cat allergen, Fel d 1, within the cat itself to reduce allergic reactions in humans. Developed by Saiba Animal Health, the vaccine utilizes a virus-like particle (VLP) platform derived from the cucumber mosaic virus (CuMV-tt) which is coupled with the recombinant Fel d 1 protein. Upon subcutaneous administration, the vaccine induces the cat's immune system to produce specific neutralizing antibodies against its own Fel d 1 protein. These antibodies bind to the allergen in the cat's secretions, such as saliva and lacrimal fluid, significantly reducing the amount of active Fel d 1 shed into the environment. This innovative approach aims to alleviate symptoms for cat-allergic individuals without requiring them to take medication or rehome their pets.

Brand names
HypoCat
Other names
Fel d 1 vaccineCat allergy vaccine

Beyond the preview

Go deeper on HypoCat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HypoCat.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call